http://www.nature.com/news/seven-days-30-november-6-december-2012-1.11931
Mess in Texas The Cancer Prevention and Research Institute of Texas (CPRIT) announced the freezing of an US$11-million commercialization grant to Peloton Therapeutics in Dallas on 29 November, after an audit revealed that the 2010 award was made without commercial or scientific review (see go.nature.com/ctjei4). The finding comes on the heels of months of controversy about an $18-million unreviewed CPRIT grant to the University of Texas MD Anderson Cancer Center in Houston (see Nature 486, 169–171; 2012).
No comments:
Post a Comment